UBS AM’s FibroGen FGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,203
Closed -$1.96M 2622
2023
Q2
$1.96M Hold
4,203
﹤0.01% 1654
2023
Q1
$1.96M Buy
4,203
+115
+3% +$53.7K ﹤0.01% 1654
2022
Q4
$1.64M Buy
4,088
+826
+25% +$331K ﹤0.01% 1624
2022
Q3
$1.06M Sell
3,262
-241
-7% -$78.4K ﹤0.01% 1933
2022
Q2
$925K Sell
3,503
-109
-3% -$28.8K ﹤0.01% 2006
2022
Q1
$1.09M Buy
3,612
+785
+28% +$236K ﹤0.01% 2086
2021
Q4
$997K Sell
2,827
-537
-16% -$189K ﹤0.01% 2213
2021
Q3
$860K Buy
3,364
+74
+2% +$18.9K ﹤0.01% 2250
2021
Q2
$2.19M Sell
3,290
-502
-13% -$334K ﹤0.01% 1803
2021
Q1
$3.29M Buy
3,792
+6
+0.2% +$5.21K ﹤0.01% 1533
2020
Q4
$3.51M Buy
3,786
+253
+7% +$235K ﹤0.01% 1447
2020
Q3
$3.63M Buy
3,533
+543
+18% +$558K ﹤0.01% 1286
2020
Q2
$3.03M Sell
2,990
-93
-3% -$94.2K ﹤0.01% 1347
2020
Q1
$2.68M Sell
3,083
-9,346
-75% -$8.12M ﹤0.01% 1296
2019
Q4
$13.3M Hold
12,429
0.01% 864
2019
Q3
$11.5M Buy
12,429
+635
+5% +$587K 0.01% 915
2019
Q2
$13.3M Sell
11,794
-2,417
-17% -$2.73M 0.01% 871
2019
Q1
$19.3M Sell
14,211
-227
-2% -$308K 0.01% 749
2018
Q4
$16.7M Buy
14,438
+5,216
+57% +$6.04M 0.01% 741
2018
Q3
$14M Sell
9,222
-333
-3% -$506K 0.01% 849
2018
Q2
$15M Sell
9,555
-543
-5% -$850K 0.01% 845
2018
Q1
$11.7M Sell
10,098
-201
-2% -$232K 0.01% 898
2017
Q4
$12.2M Buy
10,299
+1,604
+18% +$1.9M 0.01% 868
2017
Q3
$11.7M Buy
8,695
+329
+4% +$442K 0.01% 865
2017
Q2
$6.76M Buy
8,366
+7,898
+1,688% +$6.38M 0.01% 967
2017
Q1
$288K Buy
+468
New +$288K ﹤0.01% 2026
2016
Q4
Sell
-9,214
Closed -$4.77M 2545
2016
Q3
$4.77M Sell
9,214
-279
-3% -$144K 0.01% 1033
2016
Q2
$3.9M Buy
9,493
+3,152
+50% +$1.29M ﹤0.01% 1092
2016
Q1
$3.37M Sell
6,341
-1,878
-23% -$999K ﹤0.01% 1148
2015
Q4
$6.26M Buy
8,219
+7,355
+851% +$5.6M 0.01% 993
2015
Q3
$474K Sell
864
-4,471
-84% -$2.45M ﹤0.01% 2047
2015
Q2
$3.14M Sell
5,335
-173
-3% -$102K ﹤0.01% 1213
2015
Q1
$4.32M Sell
5,508
-140
-2% -$110K ﹤0.01% 1087
2014
Q4
$3.86M Buy
+5,648
New +$3.86M ﹤0.01% 1099